[Algorithms for systemic therapy of prostate cancer, transitional cell carcinoma and renal cell carcinoma]. / Algorithmen zur Systemtherapie bei Prostata­, Urothel- und Nierenzellkarzinom.

ABSTRACT

Systemic therapy in uro-oncology is currently undergoing major changes. In the past, drug therapies only showed good treatment results in metastasized testicular tumors. New developments indicate that an improved understanding of tumor biology will lead to targeted treatment strategies for metastatic prostate, urothelial and renal cell carcinoma. In the following article, we summarize the practice-relevant innovations in systemic therapy in the guidelines on prostate cancer, transitional cell carcinoma of the bladder and renal cell carcinoma.